Prucalopride PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified Prucalopride PCD pharma franchise company offering 2 Prucalopride formulations across Tablets. Every batch is manufactured in DCGI-approved, WHO-GMP compliant facilities and supplied to franchise partners on a monopoly basis with full promotional backing.
What is Prucalopride?
Prucalopride is a gastrointestinal prokinetic agent and a selective, high-affinity agonist of the serotonin 5-HT4 receptor. By stimulating 5-HT4 receptors in the enteric nervous system it enhances colonic propulsive motility and accelerates colonic transit. Unlike older 5-HT4 agonists, its high receptor selectivity avoids the hERG-channel cardiac liability that led to the withdrawal of earlier agents in this class. It is indicated for chronic idiopathic constipation. See the compound record on PubChem.
Prucalopride Range Available for Franchise
Our Prucalopride portfolio comprises 2 formulations available in the following dosage forms: Tablets. Brand names, compositions, packing and net rates are shared on request with partners holding a valid Drug License. Contact us for the current Prucalopride price list and stock position.
Therapeutic Applications of Prucalopride
Prucalopride is indicated for chronic idiopathic constipation in adults in whom laxatives have failed to provide adequate relief, and it is used in selected cases of slow-transit constipation and opioid-induced constipation under specialist judgement. Prescriptions come chiefly from gastroenterologists, along with general physicians, colorectal surgeons and geriatricians. It is a prescription-only medicine.
Why Prucalopride is a High-Potential Molecule for Distributors
Prucalopride occupies the second-line slot in constipation management, and that is a more valuable position than it first appears. Chronic idiopathic constipation is common, under-treated and highly refractory — a large proportion of patients cycle through osmotic and stimulant laxatives without relief, and it is precisely that failed-laxative pool that prescribers convert to prucalopride. Because the drug is taken daily and the condition does not resolve, therapy is long-running. It also commands a materially higher price point than conventional laxatives, so a distributor earns more per pack while facing far less brand competition than in the crowded generic laxative shelf.
Why Choose Cafoli Lifecare for Your Prucalopride Franchise
Cafoli Lifecare works with over 1000+ franchise partners across India. Partners receive monopoly rights for their district or territory, WHO-GMP certified and DCGI-approved products, complete promotional inputs (visual aids, MR bags, samples, prescription pads, gifts), transparent net rates, and dependable dispatch. Our documentation and stock support are built for distributors who want to scale without operational friction.
References
- PubChem — Prucalopride compound record (NIH / NCBI)
- MedlinePlus — Prucalopride drug information (US National Library of Medicine)
- PubMed — clinical literature on Prucalopride
Our formulations of Prucalopride find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: